Predictive Oncology Inc.
POAI
$0.95
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.68M | -7.79M | -9.57M | -10.88M | -10.88M |
| Total Depreciation and Amortization | 910.00K | 895.00K | 881.40K | 825.70K | 825.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.50K | 773.20K | 334.20K | 567.80K | 567.80K |
| Change in Net Operating Assets | -281.10K | 2.80K | -428.30K | -234.30K | -234.30K |
| Cash from Operations | -6.23M | -6.12M | -8.78M | -9.72M | -12.82M |
| Capital Expenditure | 0.00 | 0.00 | -3.00K | 12.50K | 12.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 625.00K | 618.50K | -6.50K | -14.70K | -14.70K |
| Cash from Investing | 625.00K | 618.50K | -9.50K | -2.20K | -6.10K |
| Total Debt Issued | 264.00K | 275.10K | 275.10K | 275.10K | 275.10K |
| Total Debt Repaid | -195.80K | -233.80K | -346.20K | -260.20K | -260.20K |
| Issuance of Common Stock | 3.17M | 6.28M | 3.70M | 3.70M | 3.70M |
| Repurchase of Common Stock | -- | -- | -- | -1.50K | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -202.80K | -653.50K | -573.80K | -573.80K | -573.80K |
| Cash from Financing | 3.03M | 5.66M | 3.05M | 3.14M | 3.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.57M | 158.50K | -5.74M | -6.58M | -9.43M |